×
Hero Background

Olanzapine Companies

ID: MRFR/Pharma/0247-HCR
130 Pages
Rahul Gotadki
October 2025

Olanzapine is an antipsychotic medication used in the treatment of various mental health conditions, including schizophrenia and bipolar disorder. Olanzapine is available under different brand names, and various pharmaceutical companies may manufacture and market generic versions of the medication.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Olanzapine Market Report- Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Olanzapine Market

Olanzapine Companies

 


Latest Olanzapine Companies Updates:


Teva and Royalty Pharma Collaboration In October 2023, Teva Pharmaceuticals partnered with Royalty Pharma to accelerate the development of Olanzapine LAI (TEV-'749), a long-acting injectable form of the drug for schizophrenia. Royalty Pharma provided up to $100 million for ongoing development costs, with Phase 3 data expected in the second half of 2024.


SteadyTeq Platform Teva is utilizing the SteadyTeq platform, used for another antipsychotic, to deliver Olanzapine LAI. This technology aims to improve medication adherence and reduce hospitalizations.


List of Olanzapine Key companies in the market:



  • Dr ready’s laboratory. 

  • Watson pharmaceuticals 

  • Lilly 

  • Hamson pharmaceuticals 

  • Sun pharmaceuticals 

  • Sandoz pharmaceuticals 

  • Torrent pharmaceuticals 

  • Jubilant lifescientist